RLMD
Relmada Therapeutics Inc
3.70$
-1.6%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -58.0% | -72.3% | +7.4% | +3,742.9% | +0.9% | +89.0% | -31.5% | -36.2% | -53.0% | +105.2% | |
| – | +0.0% | -61.2% | -73.4% | +10.6% | +4,171.1% | +1.0% | +89.1% | -31.5% | -36.2% | -53.0% | +105.2% | |
| – | +0.0% | -62.2% | -79.9% | +30.9% | +1,520.3% | -93.1% | +1,681.0% | -87.9% | -24.2% | -5.7% | -9.3% | |
| – | +0.0% | -62.2% | -79.9% | +30.9% | +5,100.8% | +0.6% | +81.0% | -30.0% | -35.1% | -53.4% | +107.1% | |
| – | +0.0% | +221.1% | +10.9% | -75.3% | +1.4% | +8.7% | +8.7% | +493.3% | – | – | – | |
| – | – | -60.5% | -11.6% | -9.7% | +7.5% | +96.8% | +1,151.3% | -64.3% | – | – | – | |
| – | +2,122.2% | -99.6% | +421.8% | -40.3% | -30.5% | -74.9% | – | – | – | – | – | |
| – | +0.0% | -79.5% | -57.0% | +521.9% | -83.0% | +764.5% | +19.5% | -17.2% | -2.2% | -15.6% | -27.2% | |
| – | +0.0% | -80.4% | -55.0% | +328.9% | -75.3% | +764.5% | +19.5% | -17.2% | -2.2% | -15.6% | -37.5% | |
| – | +0.0% | +3.8% | +1.1% | +3.1% | -61.3% | – | – | – | – | – | – | |
| – | +0.0% | +50.8% | -58.0% | +44.5% | -31.7% | +1,496.9% | +34.1% | -53.0% | -33.4% | +17.8% | -62.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -20.1% | -79.3% | -477.5% | – | -8.7% | +97.3% | -32.6% | -39.2% | -58.4% | +143.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | +16.7% | +4.1% | +3.9% | +194.3% | +69.0% | +12.6% | +68.8% | +1.6% | +0.2% | +30.9% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.